Skeletal Metabolism, Fracture Risk, and Fracture Outcomes in Type 1 and Type 2 Diabetes

Author:

Sellmeyer Deborah E.1,Civitelli Roberto2,Hofbauer Lorenz C.3,Khosla Sundeep4,Lecka-Czernik Beata5,Schwartz Ann V.6

Affiliation:

1. Division of Endocrinology, Diabetes, and Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD

2. Division of Bone and Mineral Diseases, Washington University in St. Louis School of Medicine, St. Louis, MO

3. Department of Medicine III and Center for Healthy Aging, Technische Universität Dresden, Germany and Center for Regenerative Therapies Dresden, Dresden, Germany

4. Division of Endocrinology, Diabetes, Metabolism, and Nutrition Research and the Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN

5. Departments of Orthopaedic Surgery and Physiology and Pharmacology and Center for Diabetes and Endocrine Research, The University of Toledo College of Medicine and Life Sciences, Toledo, OH

6. Department of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, CA

Abstract

Fracture risk is significantly increased in both type 1 and type 2 diabetes, and individuals with diabetes experience worse fracture outcomes than normoglycemic individuals. Factors that increase fracture risk include lower bone mass in type 1 diabetes and compromised skeletal quality and strength despite preserved bone density in type 2 diabetes, as well as the effects of comorbidities such as diabetic macro- and microvascular complications. In this Perspective, we assess the developing scientific knowledge regarding the epidemiology and pathophysiology of skeletal fragility in patients with diabetes and the emerging data on the prediction, treatment, and outcomes of fractures in individuals with type 1 and type 2 diabetes.

Funder

Deutsche Forschungsgemeinschaft Sonderforschungsbereiche/Transregio 67

National Institutes of Health

American Diabetes Association

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3